BPC-157
Pure copiumNo trialsto divide attention by
Lots of attention and zero randomized-trial papers. The hype has no human trial record to point at yet.
The tool
Is it copium?
The Copium Meter. Pick a topic and find out in ten seconds how much attention it gets next to how many randomized trials back it. The number is real and sourced, the label is the joke. It rates topics, never people, and says nothing about whether anything works or is safe.
Tongkat ali
Hype is running ahead12,997yearly views per trial paper
Trials exist, but attention is far ahead of the record.
Ashwagandha
Hype is running ahead11,145yearly views per trial paper
Trials exist, but attention is far ahead of the record.
Gua sha
Hype is running ahead8,799yearly views per trial paper
Trials exist, but attention is far ahead of the record.
Finasteride
Hype is nudging ahead3,142yearly views per trial paper
Trials exist, but attention is running a step ahead of the record.
Niacinamide
Hype is nudging ahead2,785yearly views per trial paper
Trials exist, but attention is running a step ahead of the record.
Minoxidil
Hype is nudging ahead2,033yearly views per trial paper
Trials exist, but attention is running a step ahead of the record.
Retinol
Hype is nudging ahead1,968yearly views per trial paper
Trials exist, but attention is running a step ahead of the record.
Collagen
Hype is nudging ahead1,936yearly views per trial paper
Trials exist, but attention is running a step ahead of the record.
Creatine
Receipts check out814yearly views per trial paper
The trial record is deep next to the attention it gets.
Magnesium
Receipts check out777yearly views per trial paper
The trial record is deep next to the attention it gets.
Caffeine
Receipts check out595yearly views per trial paper
The trial record is deep next to the attention it gets.
Tretinoin
Receipts check out511yearly views per trial paper
The trial record is deep next to the attention it gets.
Melatonin
Receipts check out436yearly views per trial paper
The trial record is deep next to the attention it gets.
Sunscreen
Receipts check out407yearly views per trial paper
The trial record is deep next to the attention it gets.
How is it computed?
Hype is yearly English Wikipedia pageviews, a curiosity proxy and not search volume. Proof is the number of PubMed papers typed as a randomized controlled trial for the topic, from the queries on the ladder. We divide one by the other and sort the result into a tier by the rule below.
| Verdict | Rule |
|---|---|
| Receipts check out | 1,000 or fewer yearly views per trial paper |
| Hype is nudging ahead | more than 1,000 and up to 5,000 yearly views per trial paper |
| Hype is running ahead | more than 5,000 yearly views per trial paper |
| Pure copium | zero randomized-trial papers |
The first five topics were read 30 October 2026 and the other ten on 1 November 2026, all against the same attention window of October 2025 to September 2026. A trial count is depth of record, not size of effect or safety, so a deep record can still show harm and a thin one can still be a good idea. The line between tiers is ours and deliberately coarse. Read the full method.